RxDoctor Payments Data

Jeremy Yoder, PA

Physician Assistant · Dover, DENPI 1740761709

Payments from drug & device makers

$1,395in general payments, 2019–2025

Across 62 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$535
  • Amgen$168
  • Novartis$157
  • AstraZeneca$135
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$110
  • Boehringer Ingelheim$107
  • plus $183 from 3 others

What the payments were for

  • Food & beverage$1,32895%
  • Education$675%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,395 in reported general payments places this provider in the 80th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$5,312
Medicare patients
24
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban144$203,045
EntrestoSacubitril/Valsartan39$68,242
JardianceEmpagliflozin38$57,035
FarxigaDapagliflozin Propanediol21$30,729
Repatha SureclickEvolocumab24$21,998
Dofetilide15$5,363
Rosuvastatin Calcium71$3,787
Flecainide Acetate42$3,716
Metoprolol Succinate106$2,102
Atorvastatin Calcium122$1,939
Ezetimibe46$1,359
Amiodarone Hcl24$1,133
Losartan Potassium100$1,103
Amlodipine Besylate119$1,095
Bumetanide19$790

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$79$203,045144 claims
NovartisEntresto$157$68,24239 claims
Boehringer IngelheimJardiance$107$57,03538 claims
AstraZenecaFarxiga$135$30,72921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 527 physician assistant providers in Delaware.

Other physician assistant in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →